Not applicableUnknownNCT05904067
What this trial is testing
Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation
Who this might be right for
COVID-19Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 72